Prot #MM-141-07-02-02:A Randomized, Double-blind, Placebo-controlled Phase 2 Study of MM-141 plus Nab-paclitaxel and Gemcitabine versus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date5/22/15 → 5/22/18

Funding

  • Clintrax Global, Inc. (MM-141-07-02-02 // MM-141-07-02-02)
  • Merrimack Pharmaceuticals, Inc (MM-141-07-02-02 // MM-141-07-02-02)